OrthoPediatrics Corp. v. Wishbone Medical, Inc.

District Court, N.D. Indiana·Decided October 4, 2022·No. 3:20-cv-00929·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA SOUTH BEND DIVISION

ORTHOPEDIATRICS CORP., et al.,

Plaintiffs,

v. Case No. 3:20-CV-929 JD

WISHBONE MEDICAL, INC., et al.,

Defendants.

OPINION AND ORDER The Plaintiffs in this case allege that the Defendants are infringing on a patented computer program that makes it easier for orthopedic professionals to correctly position bones for optimal healing. The parties have conferred and remain divided on how three phrases within the disputed patent’s claims should be construed. The parties have fully briefed their disputes and presented oral argument at a hearing before the Court on August 29, 2022. The Court now resolves the outstanding claim construction disputes.

A. Factual Background Orthopedic professionals sometimes use devices called external fixators to treat patients suffering from broken bones or other bone abnormalities. An external fixator fits around an individual’s limb and often has a certain number of struts that run into the limb and attach to the bone to ensure the bone is positioned for proper healing. Prior to the advent of the patented technology at issue in this case, orthopedic professionals had to rely on their own estimations and experience to determine exactly how to position the external fixator and accompanying struts on a limb. (DE 105-2 at 1:15–44) (“Patent”). The new technology, patented under patent number 10,258,377 (“‘377 Patent”), allows orthopedic professionals to look at an X-ray or other photographic image of a patient’s bone and the fixator apparatus on a computer screen, use a mouse or other device to inscribe lines and points on the images as needed, and then generate calculations showing the optimal way to position the bones using the external fixator. (DE 105-2 at 1:48–2:39, 3:13–67.)

Plaintiff Orthex LLC, a wholly owned subsidiary of Plaintiff OrthoPediatrics Corp., is the assignee of the ‘377 Patent, and Plaintiff Vilex, a medical device company, is an exclusive licensee. (DE 33 at 3.) The three Plaintiffs sued Defendants Wishbone Medical, Inc., an OrthoPediatrics competitor, and Nick Deeter, an OrthoPediatrics founder who is now chairman and chief executive officer of Wishbone, in part because they allege that Wishbone is already or is imminently going to be infringing on the ‘377 Patent through the sale, use, and promotion of Wishbone’s Smart Correction External Fixation System, which allegedly copies the process described in the ‘377 Patent. Those allegations underly the Plaintiffs’ surviving claims for patent infringement (Count 1) and declaratory judgment of infringement (Count 2). The three Plaintiffs brought each of the infringement-related claims only against Defendant Wishbone. (DE 33 at 26,

37; DE 68 at 30.) There is also a surviving claim for breach of contract that OrthoPediatrics brought against Mr. Deeter. (DE 33 at 40; DE 68 at 30.) The parties’ claim construction disputes center on three phrases within the Patent as well as on the relevant Person of Ordinary Skill in the Art (“POSITA”) description that the Court will use to analyze the disputes. The parties’ first dispute is over the meaning of the bolded language in the excerpt: Taking at least two medical images of a patient to create two views, with each view’s showing at least one bone with at least one external fixator, said external fixator comprising external fixator hardware having at least one ring and said ring’s further forming a part of a six-axis external fixator device and further comprising fixator hardware, with said at least two views being oriented from different angles and displayed on said input screen . . . (DE 105-2 at 14:44–52) (emphasis added). Their second dispute is over the meaning of the bolded language in the excerpt: providing a computer, said computer having an input screen in association therewith wherein said input screen has a plurality of sensors associated therewith to detect and register a plurality of position data inscribed on said input screens . . . (DE 105-2 at 14:33–40) (emphasis added). And their third dispute is over the meaning of the bolded language in the excerpt: Marking by said orthopedic professional one or more points or one or more lines on said input screen to create said position data, with said position data’s representing either or both of a position or positions of a bone, bones, bone segments, joint space, anatomic loci or osteotomy or one or more elements of said external fixator hardware . . . (DE 105-2 at 14:53–59) (emphasis added). The parties have each filed their respective claim construction briefs and responses and have had the opportunity to present their arguments orally in a hearing before the Court. (DE 105; DE 107; DE 109; DE 110; DE 116.)

B. Standard of Review As a matter of law, the Court must construe the patent claims for a jury. Markman v. Westview Instruments, Inc., 52 F.3d 967, 977 (Fed. Cir. 1995). Claim construction is crucial because it “defines the scope of the protected invention.” Bell Commc’ns Research, Inc. v. Vitalink Commc’ns Corp., 55 F.3d 615, 619 (Fed. Cir. 1995). When interpreting a disputed claim, the court must first look at the intrinsic evidence of record—the patent itself, including the claims, the specification, and, if in evidence, the prosecution history. Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996). The process begins with the words of the claims. Teleflex, Inc. v. Ficosa North American Corp., 299 F.3d 1313, 1324 (Fed. Cir. 2002). “It is a bedrock principle of patent law that the claims of a patent define the invention to which the patentee is entitled the right to exclude.” Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005) (internal quotations and citations omitted); Teleflex, 299 F.3d at 1324 (“The claim language defines the bounds of claim scope.”). Absent an

express intent otherwise, claim terms should be given “the ordinary and customary meaning . . . that the term would have to a person of ordinary skill in the art in question at the time of the invention.” Phillips, 415 F.3d at 1313. “[T]he context of the surrounding words of the claim also must be considered in determining the ordinary and customary meaning of those terms.” ACTV, Inc. v. Walt Disney Co., 346 F.3d 1082, 1088 (Fed. Cir. 2003). However, the claims do not stand alone and they “must be read in view of the specification, of which they are a part.” Phillips, 415 F.3d at 1315 (quoting Markman, 52 F.3d at 979). The specification includes the drawings and the written description of the invention. Playtex Prods., Inc. v. Procter & Gamble, Co., 400 F.3d 901, 909 (Fed. Cir. 2005). The specification “is always highly relevant to the claim construction analysis. Usually, it is

Free access — add to your briefcase to read the full text and ask questions with AI

OrthoPediatrics Corp. v. Wishbone Medical, Inc., (N.D. Ind. 2022).

OrthoPediatrics Corp. v. Wishbone Medical, Inc. (OrthoPediatrics Corp. v. Wishbone Medical, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Praxair, Inc. v. Atmi, Inc.
543 F.3d 1306 (Federal Circuit, 2008)
Daiichi Sankyo Co., Ltd. v. Apotex, Inc.
501 F.3d 1254 (Federal Circuit, 2007)
Aquatex Industries, Inc. v. Techniche Solutions
419 F.3d 1374 (Federal Circuit, 2005)
Playtex Products, Inc. v. Procter & Gamble Co.
400 F.3d 901 (Federal Circuit, 2005)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Chef America, Inc. v. Lamb-Weston, Inc.
358 F.3d 1371 (Federal Circuit, 2004)
Technology Licensing Corp. v. Videotek, Inc.
545 F.3d 1316 (Federal Circuit, 2008)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Biosig Instruments, Inc. v. Nautilus, Inc.
783 F.3d 1374 (Federal Circuit, 2015)
Berkheimer v. Hp Inc.
881 F.3d 1360 (Federal Circuit, 2018)